Cyberdyne Inc (CYBQY) fair value: what the stock is really worth
We calculate from audited financials what Cyberdyne Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch Cyberdyne Inc ADR for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
60‑month range $0.8810 – $4.97 · fair‑value band $0.3300 – $0.3900 · the $1.43 price screens above the $0.3600 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains robotic equipment and systems for medical and welfare in Japan, the United States, Europe, the Middle East, Africa, and the Asia Pacific countries.
Show more
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains robotic equipment and systems for medical and welfare in Japan, the United States, Europe, the Middle East, Africa, and the Asia Pacific countries. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; Acoustic X, a high-speed light pulse LED array light source that enables real time photoacoustic imaging; and CYIN for living support, which is an interface that uses biological information that can be controlled voluntarily outside of muscle activities. It also provides Cybernics Treatment, a treatment that uses HAL to enhance and regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; Neuro HALFIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT at home for enhancement of physical functions. In addition, the company provides rescue support in disaster sites, and heavy labor support for factories and plants, as well as engages in the entertainment business. CYBERDYNE Inc. was incorporated in 2004 and is headquartered in Tsukuba, Japan.
Stock analysis
Cyberdyne Inc ADR (CYBQY) currently trades at $1.43, while our model-based Fair Value estimate is $0.3600, implying the stock looks roughly 297.3% overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of $0.8233 per share, and 0 of the 18 models we run sit above the $1.43 price.
Bear case: the Earnings-Based group reads lowest at $0.0578, and 18 of the 18 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.3300 (bear) to $0.3900 (bull), the price of $1.43 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Cyberdyne Inc ADR reported revenue of $4.1B in FY2026 versus $2.2B in FY2022, a compound +17.4%/yr. Reported net income was $162M in FY2026.
Key figures
Market cap $302M · P/S ratio 0.08 · Net margin 4.0% · Return on equity 0.4% · Return on assets (EBIT) −2.5% · Operating margin −34.3% · Revenue (TTM) $3.8B · Revenue growth (YoY) −21.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 38% below its 52-week high and 62% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 0% fair-value upside, at −75%, CYBQY screens richer than that median.
Fair Value models
Bear $0.3300Fair Value $0.3600Bull $0.3900
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.79/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−7.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.8%
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.0%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−37.3% (2021) → −28.7% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 356 stocks
Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside−88% · Bottom 25%
Profitability
Return on equity (TTM)0% · Below median
Return on assets−1% · Below median
Net margin (TTM)4% · Below median
Operating margin (TTM)−34% · Bottom 25%
Growth and dividend
Revenue growth−22% · Bottom 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/S (TTM)0.08× · Cheapest 25%
P/FCF1.5× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 6
FUTURE (revenue growth)0· sector 31
PAST (return on equity)1· sector 8
HEALTH (low debt)100· sector 97
DIVIDEND (yield)0· sector 37
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Cyberdyne Inc (CYBQY) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of $0.3600 versus a price of $1.43, about −75% upside (overvalued).
What is the fair value of CYBQY?
Our model-based fair value for Cyberdyne Inc ADR is $0.3600 (as of Sep 13, 2026), built from audited fundamentals. The current price: $1.43.
What is the quality score of CYBQY?
Cyberdyne Inc ADR has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cyberdyne Inc (CYBQY)?
Our model-based price target is the fair value of $0.3600 (as of Sep 13, 2026) from 18 valuation models. Cautious scenario $0.3300, optimistic scenario $0.3900. It is a calculation from audited fundamentals, not an analyst target.
What is the Cyberdyne Inc ADR stock forecast for 2026?
Our models put fair value at $0.3600, about −75% upside versus a price of $1.43 (overvalued). Cautious scenario $0.3300, optimistic scenario $0.3900. The calculation is refreshed regularly with new filings.
What is the revenue of Cyberdyne Inc (CYBQY)?
Cyberdyne Inc ADR reported trailing-twelve-month revenue of about $3.8B (latest available figure, as of Sep 13, 2026).
What is the intrinsic value of Cyberdyne Inc (CYBQY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cyberdyne Inc ADR it is $0.3600 per share (as of Sep 13, 2026), against a price of $1.43. It is the blended result of 18 valuation models (cash flow, earnings, asset, dividend).
Is Cyberdyne Inc ADR stock overvalued or undervalued in 2026?
As of Sep 13, 2026, CYBQY trades above its calculated fair value: price $1.43, fair value $0.3600, a gap of about −75% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CYBQY?
No. The price is what the market pays today ($1.43); the fair value is what the company's own numbers justify ($0.3600). For Cyberdyne Inc ADR the two are $1.07 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cyberdyne Inc ADR worth?
The market values Cyberdyne Inc ADR at about $302M (market capitalisation, as of Sep 13, 2026). Per share that is $1.43; our models calculate a fair value of $0.3600 per share.
What do the bullish and bearish scenarios say about CYBQY?
Our models span a range for Cyberdyne Inc ADR: cautious scenario $0.3300, base $0.3600, optimistic $0.3900 per share (as of Sep 13, 2026, price $1.43). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cyberdyne Inc (CYBQY)?
Balance-sheet figures for Cyberdyne Inc ADR (as of Sep 13, 2026): return on equity 0.4%. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is CYBQY from its 52-week high?
Cyberdyne Inc ADR trades at $1.43, about 38% below its 52-week high of $2.32 and 62% above the low of $0.8810 (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of $0.3600 is for.
Which stocks are comparable to Cyberdyne Inc ADR?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cyberdyne Inc ADR stock attractive at the current price?
The data as of Sep 13, 2026: price $1.43, calculated fair value $0.3600 (−75%), Quality Score 57/100, from 18 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CYBQY calculated?
We run Cyberdyne Inc ADR through 18 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.3600, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Cyberdyne Inc ADR itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Cyberdyne Inc ADR right now?
The price sits above even our optimistic bull case ($0.3900). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Cyberdyne Inc ADR
How large is the market capitalisation of Cyberdyne Inc (CYBQY)?
The market capitalisation of Cyberdyne Inc ADR is $302M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cyberdyne Inc (CYBQY)?
The price-to-sales ratio of Cyberdyne Inc ADR is 0.08 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Cyberdyne Inc (CYBQY)?
The net margin of Cyberdyne Inc ADR is 4.0% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cyberdyne Inc (CYBQY)?
The return on equity (ROE) of Cyberdyne Inc ADR is 0.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cyberdyne Inc (CYBQY)?
On an EBIT basis the return on assets of Cyberdyne Inc ADR is −2.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cyberdyne Inc (CYBQY)?
The operating margin of Cyberdyne Inc ADR is −34.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cyberdyne Inc (CYBQY)?
Revenue at Cyberdyne Inc ADR is growing −21.6% versus a year earlier (3y avg +7.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cyberdyne Inc (CYBQY)?
Earnings per share at Cyberdyne Inc ADR are growing +22.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Cyberdyne Inc (CYBQY) generate?
The free cash flow of Cyberdyne Inc ADR is $193M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Cyberdyne Inc (CYBQY) hold?
Cyberdyne Inc ADR holds more cash than debt, $8.3B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Cyberdyne Inc ADR in the live analysis
One click puts Cyberdyne Inc ADR on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 13, 2026